Alyson N Fox, M.D.
About Alyson N Fox, M.D.:
Dr. Alyson Fox earned her BA in Public Health at the Johns Hopkins University prior to attending the Mount Sinai School of Medicine. She completed her residency in Internal Medicine at NewYork-Presbyterian Weill Cornell Medical Center, where she served as assistant chief resident. She completed her Gastroenterology fellowship at the University of Pennsylvania. While at Penn, she completed a Masters in Clinical Epidemiology and served as chief fellow. She completed her advanced fellowship training in Advanced Transplant Hepatology at the University of California, San Francisco and was named clinical fellow of the year by the Department of Medicine.
Dr. Fox's clinical practice is focused on the management of patients with a variety of liver diseases including viral hepatitis, alcoholic and non-alcoholic fatty liver diseases, inherited and autoimmune liver diseases and liver cancers. As a transplant hepatologist, she has advanced training in the management of the complications of end stage liver disease and caring for patients both pre- and post- liver transplantation.
As the medical director of the adult transplant program, she oversees the program operations, protocols, outcomes and initiatives. When she is not caring for patients, she is active as a course director and educator at the Columbia University Vagelos College of Physicians and Surgeons.
Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver
Expertise:
Interests:
Languages:
Appointments:
Education:
New Patients:
Locations
Primary Locations:
CUIMC/Presbyterian Hospital and Vanderbilt Clinic
622 West 168th Street
Floor 14
New York, NY 10032
- For new and current patient appointments, call:
- (212) 305-0914
Other Locations:
ColumbiaDoctors - Midtown
51 West 51st Street
Suite 380
New York, NY 10019
ColumbiaDoctors - Glenpointe
300 Frank W Burr Blvd
Suite 130
Teaneck, NJ 07666
Insurances:
Please contact the doctor's office directly to verify that your particular insurance is accepted.
Publications:
Kaplan A, Aby E , Scott S , Sonnenday C, Fox A, Mathur A, Olthoff K , Heimbach J, Ladin K, Emamaullee J, NALLDIG Consortium. Financial toxicity in living donor liver transplantation: a call to action for financial neutrality. Am J Transplant. 2024 May 17:S1600-6135.
Ivanics T, Claasen MPAW, Samstein B, Emond JC, Fox AN, Pomfret E, Pomposelli J, Tabrizian P, Florman SS, Mehta N, Roberts JP, Emamaullee JA, Genyk Y, Hernandez-Alejandro R, Tomiyama K, Sasaki K, Hashimoto K, Nagai S, Abouljoud M, Olthoff KM, Hoteit MA, Heimbach J, Taner T, Liapakis AH, Mulligan DC, Sapisochin G, Halazun KJ; North American Living Liver Donor Innovation Group (NALLDIG). Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience. Ann Surg. 2024 Jan 1;279(1):104-111.
*Palte E, Duong JK, Remotti H, Burt J, Makkar J, Samstein B, Verna EC, Marratta D, Emond JC, Fox AN. Vibration Controlled Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation.Transplantation. 2023 Sep 1;107(9):1991-1998.
Kaplan A, Wahid N, Lee J, Fortune B, Halazun K, Fox A, Brown R, Samstein B, Rosenblatt R. Sociodemographic characteristics of living liver donors: Few changes over 20 years. Clin Transplant. 2022 Jul;36(7):e14701.
Fox AN, Liapakis A, Batra R, Bittermann T, Emamaullee J, Emre S, Genyk Y, Han H, Jackson W, Pomfret E, Raza M, Rodriguez-Davalos M, Rubman Gold S, Samstein B, Shenoy A, Taner T, Roberts JP; North American Living Liver Donor Innovations Group (NALLDIG). The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidance. Hepatology. 2022 Jun;75(6):1579-1589.
Rosenblatt R, Wahid N, Halazun KJ, Kaplan A, Jesudian A, Lucero C, Lee J, Dove L, Fox A, Verna E, Samstein B, Fortune BE, Brown RS Jr. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States. Hepatology. September 2021; 74(3): 1523-32.
Pereira MR, Aversa MM, Farr MA, Miko BA, Aaron JG, Mohan S, Cohen DJ, Husain SA, Ratner LE, Arcasoy S, Uriel N, Zheng EX, Fox AN, Tsapepas DS, Emond JC, Verna EC. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study. Am J Transplant. 2020 Nov;20(11):3198- 3205.
Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, Fox AN, Zucker J, Verna EC. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort. Hepatology. 2020 May 30.
Lawrence ZE, Martinez M, Lobritto S, Chen J, Breslin N, Fox A, Vittorio J. Adherence, Medical Outcomes, and Health Care Costs in Adolescents/Young Adults Following Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):183-189.
Al-Obaid LN, Bazarbashi AN, Cohen ME, Kim J, Lei Y, Axelrad JE, Fox A, Chandra S, Gordon FD. Enteric tube placement in patients with esophageal varices: Risks and predictors of postinsertion gastrointestinal bleeding. JGH Open. 2019 Sep 10;4(2):256-259.
Kawut SM, Ellenberg SS, Kowka MJ, Goldberg D, Vargas H, Koch D, Sharkowski T, Al-Naamani, Fox A, Brown R, Levitsky J. Oh JK, Lin G, Song N, Mottram C, Doyle MF, Kaplan DE, Gupta S, Fallon MB. Sorafenib in Hepatopulmonary Syndrome (SHPS): A Randomized, Double-Blind Placebo- Controlled Trial. Liver Transpl. 2019 Aug;25(8):1155-1164.
Przybyszewski EM, Verna EC, Lobritto SJ, Martinez M, Vittorio JM, Fox AN, Samstein B, Kato T, Griesemer AD, Emond JC. Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children. Transplantation 2018 June;102(6):953-60
Halazun KJ, Rana AA, Fortune B, Quillin RC 3rd, Verna EC, Samstein B, Guarrera JV, Kato T, Griesemer AD, Fox A, Brown RS Jr, Emond JC. No country for old livers? Examining and optimizing the utilization of elderly liver grafts. Am J Transplant. 2018 Mar;18(3):669-678.
Dew MA, Butt Z, Liu Q, Simpson MA, Zee J, Ladner DP, Holtzman S, Smith AR, Pomfret EA, Merion RM, Gillespie BW, Sherker AH, Fisher RA, Olthoff KM, Burton JR Jr, Terrault NA, Fox AN, DiMartini AF. Prevalence and Predictors of Patient-Reported Long-Term Mental and Physical Health After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL). Transplantation. 2017 Sep 6.
Samstein B, Griesemer A, Cherqui D, Mansour T, Pisa J, Yegiants A, Fox AN, Guarrera JV, Kato T, Halazun KJ, Emond J. Fully laparoscopic left-sided donor hepatectomy is safe and associated with shorter hospital stay and earlier return to work: A comparative study. Liver Transpl. 2015 Jun; 21(6):768-73.